ID: MRFR/HC/6317-HCR | February 2021 | Region: Global | 110 pages
Clinical trials which is also called as clinical research study, is a scientific study performed to evaluate the efficacy, efficiency and effects of experimental medical treatments on health. Clinical trials also help to find which medical methods work best for certain diseases or groups of people which helps to standardize the dosage according to the patient.
The globalization and increase in new product development in healthcare sector has increased the clinical trials market. The other key factors driving thegrowth are development of new treatments methods such as personalized medicine, growing evolution in technology, and rising demand for contract research organization (CROs) to conduct clinical trials.
Many pharmaceutical companies are working with different CRO to enhance its product portfolio and drive innovation. Novartis AG a leading healthcare company publishes a summarized detail of all clinical trials performed by the company to maintain transparency of their clinical trials. However, the high cost, stringent government regulations affects the clinical trials growth.
Figure 1: - Global Clinical Trials Market Share, By Region
Sources: WHO, Centres for Medicare & Medicaid Services, annual reports, press release, white paper, and company presentation
The global clinical trials industry is segmented on the basis of phase, study design, indication and end users. On the basis of the phase, the market is categorized into phase I, phase II, phase III, and phase IV. On the basis of study design, the global clinical trials market is segmented into interventional, observational and expanded access. On the basis of indication, the global clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, central nervous system (CNS) condition, diabetes, obesity, cardiovascular and others. On the basis of the end-user, the clinical trials market is segmented into dental hospitals & clinics, dental institutes and dental academic and research institutes.
Sources: WHO, Centres for Medicare & Medicaid Services, Centres for Disease Control and Prevention, Eurostat, Indian Brand Equity Foundation, Annual Reports, Press Release, White Paper, and Company Presentations.
|Market Size||Significant Value|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Phase, Study design, Indication and End users|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Charles River Laboratories,Paraxel International Corporation, Quintiles IMS, ICON plc, SGS SA, Eli Lilly and Company, Novo Nordisk A/S, Clinipace, Laboratory Corporation of America, Pfizer and Others|
|Key Market Opportunities||New product development|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
Clinical trials market is expected to exhibit a solid 5.7% CAGR over the forecast period.
The growing demand to find effective cures to chronic and infectious diseases is the major driver for the clinical trials market.
By indication, the global clinical trials market is segmented into autoimmune disorders, pain management, oncology, CNS conditions, diabetes, obesity, CVDs, and others.
The Americas dominate the global clinical trials market, followed by Europe.
Leading players in the global clinical trials market include Eli Lilly, Novo Nordisk, Quintiles IMS, Charles River Laboratories, and others.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.